Related Experiment Videos
Recurrent Pleuropericarditis Associated with Mesalazine Therapy Masked by Steroid Use
Hakan Demiröz1, Hasan Eruzun2, Handan Doğan Çakmak3
1Department of Gastroenterology, Ondokuz Mayıs University, Samsun, Turkey.
Summary
Mesalazine can cause rare pleuropericarditis in ulcerative colitis patients. Corticosteroids may mask symptoms, and effusions can mimic infection, delaying diagnosis of this serious drug side effect.
Area of Science:
- Gastroenterology
- Cardiology
- Pulmonology
Background:
- Mesalazine is a primary treatment for ulcerative colitis (UC).
- While generally safe, mesalazine can rarely cause severe cardiopulmonary issues like pleuropericarditis.
Purpose of the Study:
- To report a case of mesalazine-induced pleuropericarditis.
- To highlight diagnostic challenges and atypical presentations of this adverse event.
Main Methods:
- Case report of a patient with UC experiencing recurrent pleuropericarditis.
- Analysis of clinical presentation, diagnostic workup, and response to treatment withdrawal.
Main Results:
- The patient presented with dyspnea and effusions, initially masked by corticosteroids.
- Pericardial fluid showed a neutrophil-dominant profile, mimicking infection.
- Discontinuation of mesalazine led to rapid improvement, confirming drug-induced serositis.
Conclusions:
- Mesalazine-induced pleuropericarditis can be obscured by corticosteroids, delaying diagnosis.
- Atypical neutrophilic effusions can mimic infection, requiring high suspicion in IBD patients.
- Recurrence upon re-exposure strengthens the diagnosis of drug-induced serositis.
Related Concept Videos
Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis IV: Nursing Management
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
Pericarditis I: Introduction
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: